J Valletta

3.0k total citations
17 papers, 2.5k citations indexed

About

J Valletta is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cell Biology. According to data from OpenAlex, J Valletta has authored 17 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 4 papers in Cell Biology. Recurrent topics in J Valletta's work include Nerve injury and regeneration (11 papers), Signaling Pathways in Disease (4 papers) and Down syndrome and intellectual disability research (3 papers). J Valletta is often cited by papers focused on Nerve injury and regeneration (11 papers), Signaling Pathways in Disease (4 papers) and Down syndrome and intellectual disability research (3 papers). J Valletta collaborates with scholars based in United States, New Zealand and Switzerland. J Valletta's co-authors include William C. Mobley, Jean‐Dominique Delcroix, Chengbiao Wu, Charles L. Howe, Stephen J. Hunt, Anthony S. Kowal, Mark L. Grimes, Jie Zhou, Yiwen Li and David M. Holtzman and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and Journal of Neuroscience.

In The Last Decade

J Valletta

17 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J Valletta United States	14	1.4k	1.1k	583	550	530	17	2.5k
Jean‐Dominique Delcroix United States	12	715 0.5×	593 0.5×	389 0.7×	610 1.1×	187 0.4×	16	1.6k
Anita Bhattacharyya United States	31	1.4k 1.0×	2.1k 1.8×	444 0.8×	287 0.5×	642 1.2×	67	3.5k
Keling Zang United States	23	1.7k 1.2×	1.6k 1.4×	464 0.8×	436 0.8×	856 1.6×	27	3.8k
Makoto Sanbo Japan	29	2.1k 1.4×	2.6k 2.3×	616 1.1×	178 0.3×	501 0.9×	55	4.2k
Lucy R. Berkemeier United States	6	1.4k 1.0×	934 0.8×	529 0.9×	882 1.6×	663 1.3×	6	3.9k
Paula Dietrich United States	28	1.3k 0.9×	1.4k 1.3×	417 0.7×	378 0.7×	202 0.4×	38	2.7k
Dario Bonanomi Italy	21	990 0.7×	1.7k 1.5×	559 1.0×	200 0.4×	320 0.6×	33	2.6k
Shernaz X. Bamji Canada	32	1.9k 1.3×	2.0k 1.8×	609 1.0×	579 1.1×	604 1.1×	47	3.8k
Feng‐Quan Zhou United States	30	1.9k 1.3×	1.9k 1.7×	838 1.4×	451 0.8×	807 1.5×	51	3.8k
Igor Jakovčevski Germany	34	1.1k 0.8×	1.0k 0.9×	326 0.6×	186 0.3×	936 1.8×	68	2.9k

Countries citing papers authored by J Valletta

Since Specialization

Citations

This map shows the geographic impact of J Valletta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Valletta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Valletta more than expected).

Fields of papers citing papers by J Valletta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Valletta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Valletta. The network helps show where J Valletta may publish in the future.

Co-authorship network of co-authors of J Valletta

This figure shows the co-authorship network connecting the top 25 collaborators of J Valletta. A scholar is included among the top collaborators of J Valletta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Valletta. J Valletta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Salehi, Ahmad, Mehrdad Faizi, Damien Colas, et al.. (2009). Restoration of Norepinephrine-Modulated Contextual Memory in a Mouse Model of Down Syndrome. Science Translational Medicine. 1(7). 7ra17–7ra17. 128 indexed citations

Salehi, Ahmad, et al.. (2008). P2‐308: Examining the effects of (+)‐phenserine in Ts65Dn mouse model of down syndrome. Alzheimer s & Dementia. 4(4S_Part_14). 1 indexed citations

Wu, Chengbiao, Alfredo Ramı́rez, Bianxiao Cui, et al.. (2007). A Functional Dynein–Microtubule Network Is Required for NGF Signaling Through the Rap1/MAPK Pathway. Traffic. 8(11). 1503–1520. 61 indexed citations

Colas, Damien, J Valletta, Seiji Nishino, et al.. (2007). Sleep and EEG features in genetic models of Down syndrome. Neurobiology of Disease. 30(1). 1–7. 38 indexed citations

Salehi, Ahmad, Jean‐Dominique Delcroix, Pavel V. Belichenko, et al.. (2006). Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron Degeneration. Neuron. 51(1). 29–42. 423 indexed citations

Delcroix, Jean‐Dominique, J Valletta, Charles L. Howe, et al.. (2004). Trafficking the NGF signal: implications for normal and degenerating neurons. Progress in brain research. 146. 1–23. 47 indexed citations

Delcroix, Jean‐Dominique, J Valletta, Chengbiao Wu, et al.. (2003). NGF Signaling in Sensory Neurons. Neuron. 39(1). 69–84. 377 indexed citations

Mischel, Paul S., et al.. (2001). The Extracellular Domain of p75NTR Is Necessary to Inhibit Neurotrophin-3 Signaling through TrkA. Journal of Biological Chemistry. 276(14). 11294–11301. 77 indexed citations

Howe, Charles L., et al.. (2001). NGF Signaling from Clathrin-Coated Vesicles. Neuron. 32(5). 801–814. 281 indexed citations

10.

Yeo, Tracy T., Larry L. Butcher, Dale E. Bredesen, et al.. (1997). Absence of p75^NTRCauses Increased Basal Forebrain Cholinergic Neuron Size, Choline Acetyltransferase Activity, and Target Innervation. Journal of Neuroscience. 17(20). 7594–7605. 178 indexed citations

11.

Neve, Rachael L., et al.. (1996). A comprehensive study of the spatiotemporal pattern of β-amyloid precursor protein mRNA and protein in the rat brain: lack of modulation by exogenously applied nerve growth factor. Molecular Brain Research. 39(1-2). 185–197. 17 indexed citations

12.

Grimes, Mark L., Jie Zhou, Eric C. Beattie, et al.. (1996). Endocytosis of Activated TrkA: Evidence that Nerve Growth Factor Induces Formation of Signaling Endosomes. Journal of Neuroscience. 16(24). 7950–7964. 354 indexed citations

13.

Zhou, Jie, J Valletta, Mark L. Grimes, & William C. Mobley. (1995). Multiple Levels for Regulation of TrkA in PC12 Cells by Nerve Growth Factor. Journal of Neurochemistry. 65(3). 1146–1156. 64 indexed citations

14.

Holtzman, David M., Yiwen Li, Luis F. Parada, et al.. (1992). p140trk mRNA marks NGF-responsive forebrain neurons: Evidence that trk gene expression is induced by NGF. Neuron. 9(3). 465–478. 333 indexed citations

15.

McKinley, Michael P., Frank M. Longo, J Valletta, et al.. (1990). Chapter 19 Nerve growth factor induces gene expression of the prion protein and βbT-amyloid protein precursor in the developing hamster central nervous system. Progress in brain research. 86. 227–238. 10 indexed citations

16.

Mobley, William C., Robert H. Edwards, Richard J. Riopelle, et al.. (1989). Developmental regulation of nerve growth factor and its receptor in the rat caudate-putamen. Neuron. 3(5). 655–664. 108 indexed citations

17.

Valletta, J, et al.. (1963). [Ocular hypotension induced by hexamethonium].. PubMed. 196. 621–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact